Basal Cell Carcinoma Chemoprevention Trial (NCT05212246)
CSP #2019 - Basal Cell Carcinoma Chemoprevention Trial (B3C)
🩺 Plain-English Summary (8th-Grade Level)
This is an intent-to-treat, parallel design, multicenter randomized trial and the primary intervention is a double-blind comparison of Imiquimod (IMQ) vs. placebo cream for preventing basal cell carcinoma (BCC) of the skin on the face at one year and over 3 years after therapy. Participants will apply the IMQ or placebo cream to the face daily at bedtime for 12 weeks. This study will recruit 1630 Veterans at high risk of BCC from 17 VA medical centers.
Who can join: Review the eligibility criteria below.
Location: Providence VA Medical Center, Providence, RI — Providence, Rhode Island
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Providence VA Medical Center, Providence, RI — Providence, Rhode Island
📞 Contact the Study Coordinator
Phone: (347) 346-0380
Email: Kel.Morin@va.gov
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Basal Cell Carcinoma
- Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) — West Palm Beach, Florida
- A Study of Observation and Follow-up in People With Basal Cell Carcinoma — New York, New York
- Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma — Irvine, California
- A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma — Basking Ridge, New Jersey
- Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy — Cleveland, Ohio
Explore by condition: All Basal Cell Carcinoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.